Immunotherapy Stocks Power Higher on Celgene-Juno Deal – TheStreet.com
TheStreet.com |
Immunotherapy Stocks Power Higher on Celgene-Juno Deal
TheStreet.com Immunotherapy Stocks Power Higher on Celgene-Juno Deal. Shares of immunotherapy companies including Ziopharm Oncology and Fate Therapeutics rose early on Monday on the heels of Juno Therapeutics' announced sale to Celgene. ByArmie Margaret Lee. Jan 22 … |
